No study reported long-term IV GSH use
La Clnica Universitaria de Navarra tambin quiso investigar en este campo, haciendo un gran estudio con 20.000 pacientes, concluyendo exactamente lo mismo: la ciruga baritrica supera a los agonistas GLP-1 en prdida de peso total, reduccin de IMC y en composicin corporal
The results also raise a pressing equity question: if some groups are consistently less likely to achieve major weight loss, clinicians and researchers will need to figure out why
Stochkendahl MJ, Kjaer P, Hartvigsen J, Kongsted A, Aaboe J, Andersen M, et al
Key takeaway: Higher doses translate to roughly 1.52 kg (34 lb) of extra loss without compromising safety